FILE PHOTO: The exterior of the European Medicines Agency is seen in Amsterdam, Netherlands, December 18, 2020. REUTERS/Piroschka van de Wouw/File Photo

(Reuters) – The European medicines regulator said on Monday it would hold a meeting this week on the information gathered into whether the AstraZeneca COVID-19 vaccine contributed to thromboembolic events in those inoculated.

While its investigation is ongoing, the European Medicines Agency remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19 outweigh the risks of side effects. (

Reporting by Yadarisa Shabong in Bengaluru; Editing by Shounak Dasgupta

Our Standards: The Thomson Reuters Trust Principles.


You May Also Like

OPEC+ supply boost unlikely despite call from U.S. for more oil, says Goldman

U.S. investment bank Goldman Sachs said a recent call by the United States to OPEC+ to boost oil output is unlikely to result in higher production over the short-term given the threat to demand from the coronavirus Delta variant.

Analysis: As Fed taper inches closer, investors prepare for volatility ahead

As the Federal Reserve takes initial steps toward removing its massively accommodative policy, investors are preparing for the main show ahead.

Soccer clubs embrace cryptocurrency, but fans are divided

A growing number of major soccer clubs are launching digital coins that allow fans to vote on a variety of minor decisions as the sport faces slumping revenues caused by the coronavirus pandemic.